GB0500594D0 - Oral delivery of biological active agents in a nanoemulsion formulation to the human body - Google Patents

Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Info

Publication number
GB0500594D0
GB0500594D0 GBGB0500594.7A GB0500594A GB0500594D0 GB 0500594 D0 GB0500594 D0 GB 0500594D0 GB 0500594 A GB0500594 A GB 0500594A GB 0500594 D0 GB0500594 D0 GB 0500594D0
Authority
GB
United Kingdom
Prior art keywords
human body
active agents
oral delivery
biological active
nanoemulsion formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0500594.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RADICS ENDRE D
Original Assignee
RADICS ENDRE D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RADICS ENDRE D filed Critical RADICS ENDRE D
Publication of GB0500594D0 publication Critical patent/GB0500594D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0500594.7A 2002-06-19 2005-01-12 Oral delivery of biological active agents in a nanoemulsion formulation to the human body Ceased GB0500594D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0202032A HUP0202032A2 (hu) 2002-06-19 2002-06-19 Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által.
PCT/HU2003/000049 WO2004000274A1 (en) 2002-06-19 2003-06-18 Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Publications (1)

Publication Number Publication Date
GB0500594D0 true GB0500594D0 (en) 2005-02-16

Family

ID=89980533

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0500594.7A Ceased GB0500594D0 (en) 2002-06-19 2005-01-12 Oral delivery of biological active agents in a nanoemulsion formulation to the human body

Country Status (4)

Country Link
AU (1) AU2003244885A1 (hu)
GB (1) GB0500594D0 (hu)
HU (1) HUP0202032A2 (hu)
WO (1) WO2004000274A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3988168B1 (ja) * 2006-04-07 2007-10-10 伸司 嶋田 イチョウ葉エキスナノ微粒子による脳細胞活性効果を有する組成物
JP5459939B2 (ja) * 2006-06-09 2014-04-02 富士フイルム株式会社 カロチノイド含有エマルジョン組成物、その製造方法、それを含む食品及び化粧品
CN101759727B (zh) * 2009-09-30 2013-03-27 钱娟 一种纳米级松树皮提取物及其制备方法
PL2512648T3 (pl) * 2009-12-15 2018-07-31 Emultec S.R.L. Nanoemulsja, sposób jej otrzymywania i zastosowanie
US9468626B2 (en) 2014-03-13 2016-10-18 Chiesi Farmaceutici S.P.A. Melatonin-based formulations for parenteral administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525341A (en) * 1984-04-09 1985-06-25 Mayor Pharmaceutical Laboratories, Inc. Method of administering vitamins
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2804016B1 (fr) * 2000-01-21 2006-07-28 Oreal Nanoemulsion contenant des lipides amphiphiles et un ester de peg et utilisations
FR2804014B1 (fr) * 2000-01-21 2002-10-18 Oreal Nanoemulsion a base de lipides amphiphiles et de polymeres cationiques et utilisations
JP4549625B2 (ja) * 2002-01-05 2010-09-22 株式會社アモーレパシフィック 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物

Also Published As

Publication number Publication date
WO2004000274A1 (en) 2003-12-31
AU2003244885A1 (en) 2004-01-06
HUP0202032A2 (hu) 2004-10-28
HU0202032D0 (hu) 2002-08-28

Similar Documents

Publication Publication Date Title
DE60237199D1 (de) Heilmittelzufuhr in den körper eines patienten
HK1066466A1 (en) Pharmaceutical formulations of antineoplastic agents in particular temozolomide processes of making and using the same
EP1569691A4 (en) DISTRIBUTION OF PHARMACEUTICAL AGENTS OVER THE HUMAN INSULIN RECEPTOR
PT1944050E (pt) Melhoramentos referentes a mecanismos de accionamento adequados para utilização em dispositivos de distribuição de fármacos
HK1092084A1 (en) Improvements in and relating to drive mechanisms suitable for use in drug delivery devices
IL173013A0 (en) New branched sulfates for use in personal care formulations
PL378927A1 (pl) Stałe postacie dawkowane do żucia i sposoby dostarczania środków czynnych do trudno dostępnych powierzchni zębów
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
AU2003251127A1 (en) Improvements in and relating to control of liquid flow into or out of a human or animal body
HUP0400988A3 (en) Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
AU2003280918A8 (en) Rabbit skin comprising biological active substance and its use
GB0500594D0 (en) Oral delivery of biological active agents in a nanoemulsion formulation to the human body
EP1491210A4 (en) THERAPEUTIC DRUG COMPRISING HOLLOW PROTEIN NANOPARTICLES HAVING HOLLOW PROTEIN ANTIBODIES AND NANOPARTICLES
HUP0400924A3 (en) Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
AU2002224471A1 (en) In vivo stimulation of angiogenic activity
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
EP1583545A4 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
AU2003286206A1 (en) Use of a pear must extract as active principle in a cosmetic and/or pharmaceutical composition
AU2003257624A1 (en) Medical instrument to be implanted in the body
GB0219421D0 (en) Improvements in or relating to formulations for the delivery of drugs
GB0207596D0 (en) Improvements in or relating to patient support structures and their use
AU2003212375A1 (en) Use of ltb4 antagonists in veterinary medicine
AU2002334253A1 (en) Improvements in or relating to the delivery of oral drugs
GB0313836D0 (en) Improvements in and relating to the dispensing of medicaments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)